Circadian Activity Rhythm in Early Relapsing-Remitting Multiple Sclerosis

被引:9
|
作者
Tonetti, Lorenzo [1 ]
Camilli, Federico [2 ]
Giovagnoli, Sara [1 ]
Natale, Vincenzo [1 ]
Lugaresi, Alessandra [2 ,3 ]
机构
[1] Univ Bologna, Dept Psychol, Viale Berti Pichat 5, I-40127 Bologna, Italy
[2] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Via Altura 3A, I-40139 Bologna, Italy
[3] UOSI Riabilitaz Sclerosi Multipla, IRCCS Ist Sci Neurol Bologna, Via Altura 3A, I-40139 Bologna, Italy
关键词
actigraphy; adult; circadian rhythm; motor activity; relapsing-remitting multiple sclerosis; SLEEP DISTURBANCES; FATIGUE; ACTIGRAPHY; INSOMNIA; MODEL;
D O I
10.3390/jcm8122216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While relapsing-remitting is the most prevalent course of multiple sclerosis, the prognostic/predictive markers of the worsening of symptomatology are still debated. With reference to other diseases, the study of the circadian activity rhythm, according to the theoretical framework of the two-process model of sleep regulation and applying functional linear modeling, proved to be useful to identify a possible marker. The usefulness of the study of circadian activity rhythm in multiple sclerosis is strengthened by recent findings indicating a potential involvement of circadian factors in the multifactorial etiopathology of the disorder. The aim of the present study was to verify whether circadian activity rhythm of early relapsing-remitting multiple sclerosis patients presents specific alterations, through functional linear modeling. Thirty-five relapsing-remitting multiple sclerosis patients (24 females; mean age +/- SD = 31.51 +/- 7.74) and 35 healthy controls (24 females; mean age +/- SD = 31.29 +/- 8.02) were enrolled. They wore an actigraph around the non-dominant wrist for one week. Relapsing-remitting multiple sclerosis patients showed a peak in motor activity around 5:00 a.m., higher than that of healthy controls. The timing of the peak in motor activity in the patients could be explained according to the hyperactive hypothalamus-pituitary-adrenal axis and higher cortisol awakening response reported in these patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Oral fumarate for relapsing-remitting multiple sclerosis
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    LANCET, 2008, 372 (9648): : 1447 - 1448
  • [32] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    M. C. Buscarinu
    S. Romano
    R. Mechelli
    R. Pizzolato Umeton
    M. Ferraldeschi
    A. Fornasiero
    R. Reniè
    B. Cerasoli
    E. Morena
    C. Romano
    N. D. Loizzo
    R. Umeton
    M. Salvetti
    G. Ristori
    Neurotherapeutics, 2018, 15 : 68 - 74
  • [33] Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
    Barkhof, F.
    Hulst, H. E.
    Drulovic, J.
    Uitdehaag, B. M. J.
    Matsuda, K.
    Landin, R.
    NEUROLOGY, 2010, 74 (13) : 1033 - 1040
  • [34] Quality of life in relapsing-remitting multiple sclerosis
    Dayapoglu, Nuray
    Tan, Mehtap
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (01) : 133 - 137
  • [35] Fatigue in multiple sclerosis relapsing-remitting form
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Felipe, E
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (2B) : 471 - 475
  • [36] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [37] Executive functions in relapsing-remitting multiple sclerosis
    Elosua, M. Rosa
    Villadangos, Noelia
    APPLIED NEUROPSYCHOLOGY-ADULT, 2023,
  • [38] Relapsing-remitting multiple sclerosis and subclinical atherosclerosis
    Omerzu, T.
    Magdic, J.
    Hojs, R.
    Fabjan, T. Hojs
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 376 - 377
  • [39] Cladribine Tablets In Relapsing-Remitting Multiple Sclerosis
    Muir, Victoria J.
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (03) : 239 - 249
  • [40] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    Buscarinu, M. C.
    Romano, S.
    Mechelli, R.
    Umeton, R. Pizzolato
    Ferraldeschi, M.
    Fornasiero, A.
    Renie, R.
    Cerasoli, B.
    Morena, E.
    Romano, C.
    Loizzo, N. D.
    Umeton, R.
    Salvetti, M.
    Ristori, G.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 68 - 74